###begin article-title 0
###xml 84 88 <span type="species:ncbi:10090">Mice</span>
Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: SK VB GMG CS SR. Performed the experiments: SK SB YS EC AA CK VB SR. Analyzed the data: SK SB YS EC AA CK VB SR. Contributed reagents/materials/analysis tools: SB GMG CS SR. Wrote the paper: SK GMG CS SR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Chronic inflammation is a characteristic feature of diabetic cutaneous wounds. We sought to delineate novel mechanisms involved in the impairment of resolution of inflammation in diabetic cutaneous wounds. At the wound-site, efficient dead cell clearance (efferocytosis) is a pre-requisite for the timely resolution of inflammation and successful healing.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
Macrophages isolated from wounds of diabetic mice showed significant impairment in efferocytosis. Impaired efferocytosis was associated with significantly higher burden of apoptotic cells in wound tissue as well as higher expression of pro-inflammatory and lower expression of anti-inflammatory cytokines. Observations related to apoptotic cell load at the wound site in mice were validated in the wound tissue of diabetic and non-diabetic patients. Forced Fas ligand driven elevation of apoptotic cell burden at the wound site augmented pro-inflammatory and attenuated anti-inflammatory cytokine response. Furthermore, successful efferocytosis switched wound macrophages from pro-inflammatory to an anti-inflammatory mode.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Taken together, this study presents first evidence demonstrating that diabetic wounds suffer from dysfunctional macrophage efferocytosis resulting in increased apoptotic cell burden at the wound site. This burden, in turn, prolongs the inflammatory phase and complicates wound healing.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 479 482 467 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Ramsey1">[1]</xref>
###xml 584 587 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Brem1">[2]</xref>
###xml 730 733 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Pierce1">[3]</xref>
###xml 917 920 905 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Gillitzer1">[4]</xref>
###xml 922 925 910 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Martin1">[5]</xref>
###xml 1088 1091 1076 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Maruyama1">[6]</xref>
###xml 1093 1096 1081 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Abrass1">[7]</xref>
###xml 1169 1172 1157 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Weisberg1">[8]</xref>
###xml 1174 1177 1162 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Goren1">[9]</xref>
###xml 470 478 <span type="species:ncbi:9606">patients</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
The Centers for Disease Control and Prevention (CDC) report that diabetes affects nearly 21 million Americans i.e., approximately7% of the U.S. population. Impairment of cutaneous wound healing is a debilitating complication commonly encountered during diabetes mellitus. Foot ulcers represent the most prevalent diabetic wounds and frequently lead to limb amputations. The incidence of diabetic foot lesions has been reported to be similar in type 1 vs type 2 diabetic patients [1]. In human diabetic ulcers, multiple deviations from normal healing have been identified (reviewed in [2]. Diabetic ulcers are characterized by a chronic inflammatory state primarily manifested by imbalances in pro- and anti-inflammatory cytokines [3]. Transient self-resolving inflammation is essential for successful wound healing. Wound inflammation is driven by a variety of mediators that are tightly controlled in space and time [4], [5]. Wound-site macrophages represent a key player that drive wound inflammation. Diabetes is known to compromise macrophage function including phagocytosis activity [6], [7]. Diabetic macrophages produce high levels of pro-inflammatory cytokines [8], [9].The causative factors underlying the chronic inflammatory state of diabetic wounds remain to be characterized.
###end p 9
###begin p 10
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Singer1">[10]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Desmouliere1">[11]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Meszaros1">[12]</xref>
During the early inflammatory phase, a large number of polymorphonuclear neutrophil (PMN nearly 50% of all cells at the wound site) are recruited to the wound site [10]. Following completion of their tasks, PMN must be eliminated in order to initiate the next stage of wound healing. Non-resolving persistent inflammation may derail the healing cascade resulting in chronic wounds. In the course of adult cutaneous wound healing, the granulation tissue decreases in cellularity and evolve into a scar [11]. Rapid increase in cell infiltration during tissue reconstruction is balanced by apoptosis. Apoptosis allows for the elimination of cells that are no longer required at the injury site or cells that are too damaged to facilitate the healing process. While mechanisms of apoptosis have been intensely studied, the specific mechanisms of disposal or clearance of apoptotic cells from the wound site remain poorly understood [12].
###end p 10
###begin p 11
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-deCathelineau1">[13]</xref>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Gardai1">[14]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Vandivier1">[15]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Erwig1">[16]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Fadok1">[17]</xref>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Rosen1">[18]</xref>
Phagocytosis of apoptotic cells has distinctive morphologic features and unique downstream consequences. deCathelineau and Henson [13] and Gardai et al [14] coined the term efferocytosis [15]. Efferocytosis refers to phagocytosis of apoptotic cells, an essential feature of immune responses and critical for the resolution of inflammation. This final removal step in the cell-death program plays a critical role in protecting tissues from exposure to the toxic contents of dying cells and also serves to prevent further tissue damage by stimulating production of anti-inflammatory cytokines and chemokines [16], [17]. Inappropriate clearance of cell corpses may lead to autoimmune diseases and chronic inflammation [18]. Adequate removal of apoptotic PMNs by macrophages from the wound site is a pre-requisite for the restoration of normal tissue function resolving inflammation. In the clinical treatment of chronic wounds, debridement is commonly practiced and is aimed at the removal of dead, damaged, or infected tissue to improve the healing potential of the remaining healthy tissue. We posit that at the wound-site successful debridement at the cellular level is a pre-requisite to the resolution of inflammation and successful healing. The objective of this study was to test this novel hypothesis and to delineate mechanisms that are involved in the impairment of resolution of inflammation in diabetic wounds. This reports presents first evidence collected from functionally active macrophages harvested from diabetic wounds.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</sup>
###xml 583 593 583 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g001">Figs. 1A&#8211;B</xref>
###xml 694 703 694 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g001">Fig. 1C&#8211;E</xref>
###xml 935 942 935 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009539-t001">Table 1</xref>
###xml 1248 1254 1248 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g002">Fig. 2</xref>
###xml 1510 1519 1510 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g002">Fig. 2A&amp;B</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 815 822 <span type="species:ncbi:9606">patient</span>
###xml 925 933 <span type="species:ncbi:9606">patients</span>
Mice homozygous (BKS.Cg-m +/+ Leprdb/J or db/db) for spontaneous mutation of the leptin receptor (Leprdb) become identifiably obese around 3 to 4 weeks of age. Elevation of blood sugar was evident within 4 to 8 weeks after birth. Excisional (6 mm) wounds created on the back of these mice showed severe impairment in closure when compared to their corresponding control (heterozygous db/+) mice (data not shown). Using histological approaches, we observed that the wounds of diabetic mice contained higher number of apoptotic cells compared to the wound tissue of control db/+ mice (Figs. 1A-B). TUNEL staining and Western blot using active caspase-3 antibody demonstrated consistent outcomes (Fig. 1C-E). To test the clinical relevance of the above-said findings punch biopsies (3 mm) were collected from matched (patient characteristics, wound location and clinical condition) wounds of consented diabetic and non-diabetic patients (Table 1). Scoring of active caspase 3 positive cells demonstrated a significantly higher load of apoptotic cells in the wound tissue of individuals with diabetes (1F-G). In order to identify the types of cells in the diabetic wounds that were undergoing apoptosis, dual immunofluorescence studies were performed (Fig. 2). Wound tissue sections (d3 and d7) from diabetic animals were immunostained with active caspase-3 antibody to visualize apoptotic cells. The sections were then co-immunostained using either anti-neutrophil or anti-CD31 (endothelial cell marker) antibody Fig. 2A&B). The results clearly demonstrate that at day 3 majority of caspase-3 positive cells were neutrophils. Some endothelial cells were positive for caspase-3 on day 7 post-wounding. These data suggest PMNs, and endothelial cells at least in part, represent the apoptotic cells detected in the wounds.
###end p 13
###begin title 14
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 67 73 <span type="species:ncbi:9606">humans</span>
Increased number of apoptotic cells in wounds of diabetic mice and humans.
###end title 14
###begin p 15
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inset:</italic>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inset</italic>
###xml 494 497 490 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B&#8211;C</bold>
###xml 535 536 531 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 563 564 559 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 609 610 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 616 622 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 657 658 651 652 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 829 830 823 824 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 945 948 937 940 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#8211;G</bold>
###xml 1252 1253 1244 1245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1331 1332 1319 1320 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1434 1435 1420 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1009 1017 <span type="species:ncbi:9606">patients</span>
A, Representative mosaic images from day 3 wounds of diabetic (db/db) or non-diabetic (db/+) mice stained with active caspase 3 (brown). Counterstaining was performed using hematoxylin (blue). The mosaic images of whole wounds were collected under 20x magnification guided by MosaiX software (Zeiss) and a motorized stage. Each mosaic image was generated by combining 12-14 images. Inset: higher magnification image of the boxed area marked in the mosaic image. scale bar (inset)  = 10 microm; B-C, quantification of active caspase 3 (B) or TUNEL positive cells (C). Data are shown as mean +/- SD (n = 3); *, p<0.05 versus control non diabetic (db/+) mice; D. A representative Western blot image of active caspase-3 (casp-3) and GAPDH (housekeeping) in day3 wound tissue extracts of diabetic (db/db) or non-diabetic (db/+) mice. E. Densitometry data of blot shown in panel D. Data shown are mean +/- SD (n = 3). *, p<0.05 compared to db/+ mice; F-G, wound biopsies were obtained from non-diabetic or diabetic patients presented at the wound clinic. Specimens (3 mm punch) were obtained from the edge of wounds immunostained using active caspase 3 (brown) antibody as a marker of apoptotic cells. Counterstaining was performed using hematoxylin (blue); F. microscopic images, arrows indicate positive cells. Scale bar  = 50 microm; G, quantification of active caspase 3 positive areas shown in F. Data shown are mean +/- SD (n = 3); * p< 0.05 versus non diabetic leg wounds.
###end p 15
###begin title 16
Identification of apoptotic neutrophils and endothelial cells in diabetic wounds.
###end title 16
###begin p 17
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 122 123 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 320 325 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii-iv</italic>
###xml 368 369 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 630 631 626 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 641 642 637 638 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Representative immunostained section of: A, day 3 wound showing neutrophils (green) and active casp-3 (red) staining; and B, day 7 wound showing endothelial cells (CD31, green) and active casp-3 (red) staining. Nuclear counterstaining was performed using DAPI (blue). i, Low power (20x) images, Scale bar  = 50 microm.; ii-iv, high powered images of the boxed area in i showing active casp-3 (red) and DAPI (blue) (ii) anti-neutrophil or anti-CD31 (green) and DAPI (blue) (iii); and merged images of anti-neutrophil/anti-CD31 and active casp-3. Casp3 positive neutrophils/endothelial cells are shown with white arrows. Scale bar (Aii-iv and Bii-iv)  = 10 microm.
###end p 17
###begin title 18
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Demographic characteristic of patients and their wound size/age.
###end title 18
###begin p 19
AA, African American; C, Caucacians; M, male; F, female; ND, not determined;
###end p 19
###begin p 20
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Kaneto1">[19]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Sablina1">[20]</xref>
###xml 468 476 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009539.s001">Fig. S1A</xref>
###xml 693 701 693 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009539.s001">Fig. S1A</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Esterbauer1">[21]</xref>
###xml 1032 1040 1032 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009539.s001">Fig. S1B</xref>
###xml 1189 1197 1189 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009539.s001">Fig. S1C</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1183 1187 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">mice</span>
To test whether increased oxidative stress in diabetic mice contributes to increased number of apoptotic cells in wounds, the diabetic mice were supplemented (gavaged) daily with N-acetyl cysteine (NAC). NAC is a well known antioxidant effective in decreasing oxidative stress in diabetic mice at the abovementioned dose [19], [20]. After three weeks of supplementation, plasma lipid peroxidation levels were measured as marker for oxidative stress. Data presented in Fig. S1A demonstrate that diabetic mice, compared to the matched non-diabetic mice, show significantly high levels of lipid peroxidation. NAC supplementation for three weeks significantly decreased plasma lipid peroxidation (Fig. S1A). 4-Hydroxy-2-nonenal (HNE) is a major product of endogenous lipid peroxidation, which is found as a footprint in the aftermath of oxidative stress [21]. Anti-HNE staining demonstrated that similar to plasma, wound tissue of db/db mice exhibit higher levels of oxidative stress which is ameliorated following NAC supplementation (Fig. S1B). Despite attenuated oxidative stress following NAC supplementation, no change in apoptotic cell count in wounds was observed in the diabetic mice (Fig. S1C). These observations argue against the involvement of oxidative stress in determining the apoptotic cell load in the wound tissue of diabetic mice.
###end p 20
###begin p 21
###xml 454 460 452 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3</xref>
###xml 607 614 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3A</xref>
###xml 654 661 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3B</xref>
###xml 724 732 718 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Figs. 3C</xref>
###xml 812 819 806 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3D</xref>
###xml 860 870 854 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Figs. 3D&amp;E</xref>
###xml 909 916 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3H</xref>
###xml 1035 1044 1029 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3F&amp;G</xref>
###xml 1181 1187 1175 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g004">Fig. 4</xref>
###xml 1590 1594 1584 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Breyer1">[22]</xref>
###xml 1723 1727 1717 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Breyer1">[22]</xref>
###xml 1974 1984 1968 1978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g004">Figs. 4C&amp;D</xref>
###xml 2203 2210 2197 2204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g004">Fig. 4B</xref>
###xml 2309 2316 2303 2310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g004">Fig. 4B</xref>
###xml 2450 2457 2444 2451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g004">Fig. 4B</xref>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 210 213 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
###xml 1355 1359 <span type="species:ncbi:10090">mice</span>
###xml 1476 1480 <span type="species:ncbi:10090">mice</span>
###xml 1768 1772 <span type="species:ncbi:10090">mice</span>
###xml 1831 1835 <span type="species:ncbi:10090">mice</span>
###xml 2085 2089 <span type="species:ncbi:10090">mice</span>
###xml 2416 2420 <span type="species:ncbi:10090">mice</span>
To evaluate apoptotic cell clearance activity, homogenous wound macrophage suspensions were derived from diabetic and non-diabetic (control) mice. Wound macrophages were isolated employing a polyvinyl alcohol (PVA)-sponge implantation approach. This isolation procedure resulted in macrophage cultures with >95% (95.9+/-1.7%) homogeneity. Wound-site macrophages were co-cultured with cell-tracker (red)-tagged cells that were either apoptotic or viable (Fig. 3). Thymocytes were made apoptotic by activating them with 5 microM dexamethasone for 12 h. Over 90% cells become phosphatidylserine (PS) positive (Fig. 3A). The co-culture resulted in clasping (Fig. 3B) and phagocytosis of the fluorescent-labeled apoptotic cells (Figs. 3C). Macrophages were phagocytotically-silent when co-cultured with viable cells (Fig. 3D). The difference in observation between Figs. 3D&E were objectively tested using scores (Fig. 3H). High powered DIC or fluorescence images were utilized to discriminate between adherent and engulfed apoptotic cell (Fig. 3F&G). Significantly impaired apoptotic cell clearance or efferocytosis activity of wound macrophages isolated from diabetic mice was noted (Fig. 4). We sought to test whether the impairment in apoptotic cell clearance activity of wound macrophages was limited to the db/db model or macrophages from other diabetic mice models show comparable results. To address this issue, we used other genetic models of type 1 diabetes. The NOD/LtJ mice are susceptible to spontaneous development of autoimmune (type 1) insulin dependent diabetes mellitus (IDDM) [22]. Similarly, B6-Ins2Akita model of spontaneous type 1 diabetes is a relatively new model of non-obese insulin-dependent diabetes [22]. Consistent with results from the db/db mice, wound macrophages derived from NOD as well as from Akita mice showed increased number of apoptotic cells in wound tissue (data not shown) as well as clear impairments in dead cell clearance activity (Figs. 4C&D). Results addressing the time-course demonstrate that wound macrophages harvested form non-diabetic mice during the early inflammatory phase (day 3 post-wounding) possess the highest apoptotic cell clearance activity (Fig. 4B). This activity is attenuated during the intermediary (day 7) or late (day 15) phases of healing (Fig. 4B). Compared to controls, the phagocytic activity was markedly impaired in macrophages from diabetic mice at all time points examined (Fig. 4B).
###end p 21
###begin title 22
Dead cell clearance by wound-site macrophages.
###end title 22
###begin p 23
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 397 398 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 522 523 520 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 619 620 617 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 657 663 655 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">viable</italic>
###xml 734 735 732 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 861 864 859 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F&#8211;G</bold>
###xml 930 931 928 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 968 969 966 967 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1043 1044 1041 1042 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1114 1130 1112 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phagocytic index</italic>
###xml 1404 1405 1400 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For dead cell clearance assay, wound macrophages were co-cultured with cell-tracker labeled (red) thymocytes. A, Thymocyte apopotosis detected using Annexin V (FITC conjugated). Annexin V binds to externalized phosphatidyl serine (PS), a characteristics of apoptotic cells. Such treatment resulted in over 90% cells becoming phosphatidylserine (PS) positive. Data are mean +/- SD; p<0.05 (n = 4). B, F4/80-FITC (green) and DAPI (blue, nuclear) stained wound macrophage establishing link with an apoptotic thymocyte (red); C, wound macrophage (F4/80-FITC and DAPI stained) engulfed a number of red apoptotic thymocytes; D, co-cultures of control (untreated, viable) thymocytes (red) with wound macrophage (DIC image) followed by wash; E, co-cultures of apoptotic thymocytes (red) with wound macrophages (differential image contrast, DIC image) followed by wash; F-G, Representative high magnification image of a macrophage in DIC (F) or stained with F4/80 FITC (green, G) showing engulfed and adhered (white arrows) apoptotic thymocytes (red). H, scoring of thymocytes engulfed by macrophage. Data are presented as phagocytic index which is defined as total number of apoptotic cells engulfed by macrophages in a field of view divided by total number of macrophage presented in the view. This approach enables normalization of the data against macrophage number. Data presented as mean +/- SD (n = 3). *, p<0.01 compared to macrophage co-cultured with control thymocytes.
###end p 23
###begin title 24
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Dead cell clearance activity is impaired in wound-site macrophages harvested from diabetic mice.
###end title 24
###begin p 25
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 169 172 169 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B&#8211;D</bold>
###xml 284 285 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 429 430 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 553 554 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 733 734 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
A, representative images of macrophage (phase contrast) from diabetic (db/db) and their matched control non diabetic (db/+) co-cultured with apoptotic thymocytes (red); B-D, quantification of dead cell clearance activity of wound macrophages from three different genetic backgrounds; B, phagocytic index of wound macrophages harvested 3, 7 or 15 day post implantation from db/+ (non-diabetic control) or db/db (type 2 diabetes); C, phagocytic index of wound macrophages harvested day 5 post implantation from NOR (control) or NOD (type 1 diabetes); and D, phagocytic index of wound macrophages harvested day 5 post implantation from Akita (Ins2Akita, type 1 diabetes) & C57Bl6 (non-diabetic controls). Data are mean +/-SD (n = 3).*, p<0.05 versus control mice.
###end p 25
###begin p 26
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Eming1">[23]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Eming1">[23]</xref>
###xml 765 772 761 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g005">Fig. 5A</xref>
###xml 1479 1486 1467 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g005">Fig. 5B</xref>
###xml 1536 1543 1524 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g005">Fig. 5A</xref>
###xml 1589 1596 1577 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g005">Fig. 5B</xref>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 1096 1100 <span type="species:ncbi:10090">mice</span>
###xml 1322 1326 <span type="species:ncbi:10090">mice</span>
Transient inflammation is an integral component of the successful healing process [23]. While inflammation-derived mechanisms support key healing processes such as debris-removal and angiogenesis, it is necessary that the inflammation be resolved in a timely manner to allow the remainder of the healing cascade to follow [23]. To address mechanisms implicated in the resolution of wound inflammation, wound tissue was harvested from diabetic mice and their corresponding controls on days 1, 3, and 7 day post-wounding. Compared to corresponding control mice, diabetic mice showed increased levels of the pro-inflammatory cytokines TNF-alpha and IL-6. Of related interest, IL-10, an anti-inflammatory cytokine, was significantly lower in the diabetic wound tissue (Fig. 5A). This line of evidence demonstrates an imbalance between pro-inflammatory and anti-inflammatory cytokines in the diabetic wound antagonizing timely resolution of inflammation. Macrophages represent a major source of cytokines in the wound. Thus, cytokine production by wound macrophages isolated from diabetic and control mice was examined. Wound macrophages from db/db and db/+ control animals were isolated and cultured overnight. Next, the pro-inflammatory cytokines TNFalpha, IL-6 were assayed from the culture media. Macrophages from diabetic mice produced higher levels of the pro-inflammatory cytokines TNF-alpha & IL-6 and lower anti-inflammatory cytokine IL-10 compared to non-diabetic controls (Fig. 5B). Taken together, the results from wound tissue (Fig. 5A) as well as isolated wound-site macrophages (Fig. 5B) demonstrate that the cytokine expression pattern in the diabetic wound resist resolution of inflammation leading to a prolonged inflammatory phase.
###end p 26
###begin title 27
Increased pro-inflammatory cytokine levels in diabetic wounds and in wound-site macrophages.
###end title 27
###begin p 28
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 138 140 138 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pg</italic>
###xml 161 163 161 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mg</italic>
###xml 202 203 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 215 221 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 228 229 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 344 345 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 478 479 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 491 497 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 231 234 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
A, Cytokine levels in excisional wound tissue collected on days 1, 3 and 7 post-wounding were measured using ELISA. Data are presented as pg cytokine levels per mg of wet tissue. Mean +/- SD (n = 5).*, p<0.05 db/db versus db/+; B, PVA sponges were harvested on days 3, 7 or 15 after implantation and macrophages were isolated. Macrophages (1x106) were seeded in 6-well plates. Cytokine levels in culture media was measured 24 h post-seeding using ELISA. Mean +/- SD (n = 4). *, p<0.05 db/db versus db/+.
###end p 28
###begin p 29
###xml 570 579 570 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g006">Fig. 6A&#8211;D</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Verhoven1">[24]</xref>
###xml 886 890 886 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 1137 1144 1137 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g006">Fig. 6E</xref>
###xml 1366 1370 1366 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Kiener1">[25]</xref>
###xml 1372 1376 1372 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Matsue1">[26]</xref>
###xml 1692 1698 1682 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g007">Fig. 7</xref>
###xml 1838 1845 1828 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g006">Fig. 6F</xref>
In the next phase of the study we sought to address whether there is a link between the observed higher burden of apoptotic cells in the diabetic wound and impaired resolution of wound inflammation and closure. To increase apoptotic cell burden at the wound site with minimal perturbation of other aspects of wound biology, JO2 (anti-CD95) or its isotype control (IgG2) antibody was applied topically to wounds once per day during the early inflammatory phase (0-4 d post wounding). This approach led to a significantly higher load of apoptotic cells at the wound site (Fig. 6A-D). The Fas antigen is a death-domain containing cell surface protein that is present in many cell types [24]. Our goal, in using this approach, was to increase apoptotic cell burden caused by fas-mediated killing of neutrophils. However, we recognize that there is a possibility that other major cell types e.g. keratinocytes and macrophage present at the wound tissue may be killed by JO2. Thus, we chose to experimentally address this potential complication. Results showed that growing keratinocyte tip cells were not affected by anti-CD95 JO2 treatment (Fig. 6E). Wound macrophages were also not affected by anti-CD95 JO2 treatment (data not shown). These findings are consistent with published reports showing that these two cell types both are resistant to CD95-mediated apoptosis [25], [26]. Of outstanding interest was the observation that increasing apoptotic-cell count at the wound site caused significant increase in pro-inflammatory cytokine (TNFalpha, IL-1beta, and IL-6) expression and decreased anti-inflammatory cytokine (IL-10 and TGFbeta1) levels at the wound site on days 1 & 3 post-wounding (Fig. 7). Such an augmented inflammatory response in JO2 treated wounds was associated with impaired closure as manifested by expanded wound area (Fig. 6F).
###end p 29
###begin title 30
Topical application of Fas-activating anti-CD95 JO2 to the wound-site increased apoptotic cell count while not inducing apoptosis in keratinocytes.
###end title 30
###begin p 31
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 311 312 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 389 390 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 443 444 439 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 591 592 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 718 719 712 713 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1093 1094 1083 1084 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 90 96 <span type="species:ncbi:10090">murine</span>
A, visualization of TUNEL stained apoptotic cells in day 5 wound tissue treated with anti-murine CD95 (clone:JO2, 2 microg/wound) or vehicle containing isotype control (IgG2). Positive control (wound tissue treated with proteinase K and nuclease) showing TUNEL positive apoptotic cells with green nuclei stain; B, scoring of apoptotic cells in wound tissue sections stained with TUNEL. *, p<0.05 compared to the paired vehicle-treated wounds; C, a representative Western blot image of active caspase-3 (casp-3) and GAPDH (housekeeping) in tissue extracts from IgG2 or JO2 treated d3 wounds; D, densitometric data of blot shown in panel C. Data shown are mean +/- SD (n = 3). *, p<0.05 compared to IgG2 treated wounds; E, JO2 treatment did not induce keratinocyte apoptosis. Keratin-14 (green), active caspase-3 (red) and DAPI (blue) stained migrating epithelial tip in placebo (left) or JO2 treated (right) wounds. Scale bar  = 20 microm. Active caspase-3 staining was observed in the granulation tissue but not in the hyper-proliferative epithelium or epithelial tip following JO2 treatment; F, wound area as percentage of initial wound determined on the day 3 after wounding. Data are shown as mean +/- SD (n = 4).*, p<0.05 versus corresponding control IgG2 treated wound.
###end p 31
###begin title 32
Increasing dead cell burden in wounds resulted in increased pro-inflammatory cytokine levels.
###end title 32
###begin p 33
###xml 483 485 471 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pg</italic>
###xml 499 501 487 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mg</italic>
###xml 519 520 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Wound tissue treated with anti-CD95 JO2 or control IgG2 were harvested on days 0, 1 and 3 post-wounding. Cytokine levels from paired (control and treated) wound tissue were measured using ELISA on the indicated days post-wounding. Significant increase in pro-inflammatory cytokines (TNFalpha, IL-6, IL1beta) and decrease in levels of anti-inflammatory cytokines IL-10 and TGFbeta1 was noted in wounds that had increased apoptotic cell load. Data (mean +/-SD, n = 5) are presented as pg cytokine per mg wound tissue. *, p<0.05 compared to IgG treated control side.
###end p 33
###begin p 34
###xml 550 556 538 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g008">Fig. 8</xref>
Finally, we tested the hypothesis that successful efferocytosis "switches" the wound macrophages from a pro-inflammatory mode to an anti-inflammatory mode. Following effecrocytosis wound macrophages were activated with LPS and IFN-gamma to induce expression of TNF-alpha, as a marker of pro-inflammatory mediator. A significant suppression of inducible TNFalpha gene and protein expression was observed in post-phagocytosis macrophages (co-cultured with apoptotic cells) compared to macrophages that did not phagocytose (cultured with viable cells) (Fig. 8). These observations indicate that successful phagocytosis suppresses pro-inflammatory gene expression in macrophages leading to the concept that impaired efferocytosis in the diabetic wound may be responsible for defective resolution of inflammation.
###end p 34
###begin title 35
Efferocytosis of apoptotic cells by wound macrophages resulted in suppression of pro-inflammatory TNFalpha gene and protein expression.
###end title 35
###begin p 36
###xml 241 242 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 257 258 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 549 550 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Following apoptotic cell clearance assay the non-phagocytosed thymocytes were removed by washing and cells were challenged with LPS (1 microg/ml) and IFNgamma (10 ng/ml) for 4 h (gene expression) or 16 h (protein expression). TNFalpha gene (A) and protein (B) expression were measured using real-time PCR and ELISA, respectively. mRNA expression data are presented as % change compared to LPS+IFNgamma non-activated control samples. Protein data is expressed as concentration of TNF-alpha secreted in culture media. Data are mean +/-SD (n = 4); **, p<0.01 compared to macrophage cultured with viable cells.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Glass1">[27]</xref>
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Glass2">[28]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Wheat1">[29]</xref>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-OBrien1">[30]</xref>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Liu1">[31]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Maree1">[32]</xref>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i)</italic>
###xml 847 850 847 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii)</italic>
###xml 1108 1112 1108 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iii)</italic>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 272 278 <span type="species:ncbi:9606">humans</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
Diabetes is known to be associated with impaired phagocytic function of macrophages [27], [28], [29], [30], [31], [32]. Findings of this study collectively present maiden evidence supporting that increased count of apoptotic cells in cutaneous wounds of diabetic mice and humans is associated with compromised dead cell clearance activity of wound macrophages. The major conclusions of this study are that: i) diabetic wounds have increased apoptotic cells load which is in part due to impaired apoptotic clearance activity of the macrophages at the diabetic wound site. This conclusion is based on the observations that diabetic wounds in mouse and human have increased apoptotic cell count primarily contributed by apoptotic PMNs, and that macrophages isolated from diabetic wounds are impaired in their activity to phagocytose apoptotic cells; ii) increase in apoptotic cell burden in diabetic wounds augments inflammatory response in wounds. This conclusion is based on the observation that experimental elevation of apoptotic cell load at the wound site resulted in increased inflammatory response; and iii) impaired dead cell clearance activity in diabetic wound macrophages compromises resolution of inflammation in diabetic wounds. This is supported by the observation that successful clearance of apoptotic cell by wound macrophages attenuates the expression of inflammatory cytokines and that diabetic wound macrophages, impaired in their ability to phagocytose, produce elevated levels of pro-inflammatory cytokines.
###end p 38
###begin p 39
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Darby1">[33]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Brownlee1">[34]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Sudo1">[35]</xref>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Zhang1">[36]</xref>
###xml 501 509 <span type="species:ncbi:9606">patients</span>
Elevated apoptotic cell count is a known feature of the diabetic wound [33]. Factors other than impaired phagocytosis by macrophages, as proposed in this study, that may contribute to elevated apoptotic cell count in the diabetic wound include acceleration of apoptosis caused by advanced glycation end products (AGEs), activation of protein kinase C (PKC) and increased oxidative stress [34]. In support of glycation being involved in accelerating apoptosis of neutrophils in the peripheral blood of patients with T2DM a tight association between the rates of apoptosis with elevated HbA1c has been reported [35]. Implication of oxidative stress in accelerating apoptosis in diabetics have been proposed [36] but is not supported by observations of the current study demonstrating the effectiveness of NAC as an antioxidant but no effect of such intervention on apoptotic cell burden at the wound site.
###end p 39
###begin p 40
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-OBrien1">[30]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Maree1">[32]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Breyer1">[22]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-OBrien1">[30]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Bouma1">[37]</xref>
###xml 818 822 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Breyer1">[22]</xref>
###xml 1017 1021 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Wang1">[38]</xref>
###xml 1140 1144 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Sullivan1">[39]</xref>
###xml 1146 1150 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Trousdale1">[40]</xref>
###xml 1465 1469 1457 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Breyer1">[22]</xref>
###xml 1471 1475 1463 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Hummel1">[41]</xref>
###xml 1477 1481 1469 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Chen1">[42]</xref>
###xml 1483 1487 1475 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Chow1">[43]</xref>
###xml 1721 1725 1713 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Liu1">[31]</xref>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 796 801 <span type="species:ncbi:9606">human</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 974 979 <span type="species:ncbi:9606">human</span>
###xml 1029 1034 <span type="species:ncbi:10090">mouse</span>
###xml 1102 1107 <span type="species:ncbi:9606">human</span>
###xml 1186 1191 <span type="species:ncbi:10090">mouse</span>
Other than accelerated apoptosis, increased apoptotic cells load at the wound site may be contributed by inefficient clearance of apoptotic cells from wounds by macrophages. Peritoneal macrophages from non-obese diabetic (NOD) mice are known to engulf apoptotic cells less efficiently than those from non-diabetic mice [30], [32]. Our observation that wound derived macrophages from three different genetic models of diabetes suffer from impaired efferocytosis function is consistent with such reports. From a metabolic and related mechanistic stand-point, NOD and db/db diabetic mice have several fundamental differences [22], [30], [37]. NOD mice develop spontaneous autoimmune destruction of beta-cells at approximately 5 month of age. This model has a number of similarities with features of human type 1 diabetes [22]. In terms of early onset and an autosomal dominant mode of inheritance and primary dysfunction of the beta cells, Akita mice resemble the condition of human maturity-onset diabetes of the young [38]. Db/db mouse is an established model of deficient wound healing associated with human type 2 diabetes mellitus (T2DM) [39], [40]. The genetic basis for this inbred mouse model is a single-gene autosomal recessive defect in leptin receptor which produces leptin resistance and results in hyperphagia, obesity and the subsequent symptoms of insulin resistance, insufficient insulin secretion, hyperglycemia and elevated HbA1c (9.1+/-2.1) levels [22], [41], [42], [43]. One common feature of three above-described models is that they all suffer from hyperglycemia. Hyperglycemia associated advanced glycated end products (AGEs) have been shown to directly suppress phagocytosis activity of macrophages [31].
###end p 40
###begin p 41
###xml 73 75 73 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i)</italic>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ii)</italic>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Eming1">[23]</xref>
###xml 394 398 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Werner1">[44]</xref>
###xml 471 475 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Moore1">[45]</xref>
###xml 691 695 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Liechty1">[46]</xref>
###xml 1274 1278 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Lundberg1">[47]</xref>
###xml 1607 1611 1584 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Wetzler1">[48]</xref>
###xml 1819 1822 1788 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Goren1">[9]</xref>
###xml 2040 2043 2009 2012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Pierce1">[3]</xref>
###xml 2045 2049 2014 2018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Wetzler1">[48]</xref>
###xml 2115 2119 2084 2088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Werner1">[44]</xref>
###xml 2758 2762 2727 2731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Eming1">[23]</xref>
###xml 2764 2768 2733 2737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Hubner1">[49]</xref>
###xml 2770 2774 2739 2743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Cooper1">[50]</xref>
###xml 2940 2943 2905 2908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Goren1">[9]</xref>
###xml 3155 3159 3117 3121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Peters1">[51]</xref>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
###xml 1231 1237 <span type="species:ncbi:9606">humans</span>
###xml 1602 1606 <span type="species:ncbi:10090">mice</span>
###xml 1814 1818 <span type="species:ncbi:10090">mice</span>
###xml 2658 2662 <span type="species:ncbi:10090">mice</span>
###xml 2984 2988 <span type="species:ncbi:10090">mice</span>
Inflammation is tightly regulated by the following two types of signals: i) initiate & maintain inflammation; and ii) resolve inflammation [23]. An imbalance between the two signals, in favor of the former, results in chronic inflammation and derails the healing cascade. Pro-inflammatory cytokines IL-1alpha, IL-1beta, IL-6 and TNF-alpha are prominently up-regulated during the repair process [44]. IL-10 is recognized as a major suppressor of the inflammatory response [45]. An important role of this anti-inflammatory cytokine in attenuating the expression of pro-inflammatory cytokines in fetal wounds resulting in minimized matrix deposition and scar-free healing has been demonstrated [46]. Increased levels of the pro-inflammatory cytokines TNF-alpha and IL-6 and a decreased level of IL-10, an anti-inflammatory cytokine were observed in diabetic wound tissue compared to non-diabetic healing wound. A modest yet significant decrease in IL-10 levels in db/db mice wound compared to non-diabetic control suggests that IL-10 alone is not sufficient in suppressing the augmented inflammatory response in the wounds of these mice. Interestingly, increased expression of IL-10 is known to be associated with impaired healing in humans chronic venous insufficiency ulcers [47] that are known to have persistent inflammation. The specific significance of IL-10 in regulating diabetic wound inflammation remains to be characterized. Persistent (day 13 post wounding) expression of the inflammatory cytokines IL-1alpha and TNF-alpha was observed in an excisional wound healing model in diabetic (db/db) mice [48]. Lowering of the functionally available levels of the pro-inflammatory cytokine TNF-alpha using anti-TNF-alpha therapy directed at managing activated macrophages restore diabetic wound healing in ob/ob mice [9]. These lines of evidence suggest that the perturbation of a delicate balance between pro-inflammatory and anti-inflammatory cytokines in the diabetic wound predisposes the wound to impaired resolution of inflammation [3], [48]. Macrophages represent a major source of the cytokines in wounds [44]. The kinetics of cytokine production by wound macrophages was not concurrent with the dynamics of tissue wound cytokines. However, the observation that macrophages derived from diabetic wounds produces increased levels of pro-inflammatory cytokines compared to the non-diabetic control macrophages support that the augmented pro-inflammatory state of diabetic wound tissue is at least in part due to increased pro-inflammatory phenotype of the diabetic wound macrophages. This contention is supported by studies using macrophage depleted mice where a key role of macrophages in wound cytokine/growth factor dynamics has been demonstrated [23], [49], [50]. TNF-alpha expressing macrophages in diabetic animals have been also shown to be are primarily responsible for the impairment of wound healing in this genetic model [9] The macrophages isolated from CD18 null mice exhibit impaired phagocytic clearance of PMNs, impaired wound closure and a marked reduction of TGF-beta1, an anti-inflammatory growth factor released by macrophages [51]. These two studies further support the contention that the pro-inflammatory state of wound macrophage plays a major role in compromising the resolution of inflammation in diabetic wounds.
###end p 41
###begin p 42
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Cohen1">[52]</xref>
###xml 195 203 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Liles1">[53]</xref>
###xml 1504 1508 1504 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Rosen1">[18]</xref>
###xml 1640 1647 1640 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1647 1651 1647 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Haslett1">[54]</xref>
###xml 1653 1657 1653 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Lawrence1">[55]</xref>
###xml 1659 1663 1659 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Savill1">[56]</xref>
###xml 1806 1810 1806 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Savill1">[56]</xref>
###xml 1812 1816 1812 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Manfredi1">[57]</xref>
###xml 1818 1822 1818 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Ren1">[58]</xref>
###xml 1824 1828 1824 1828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Savill2">[59]</xref>
###xml 2129 2133 2122 2126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Savill1">[56]</xref>
###xml 2135 2139 2128 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Fadok2">[60]</xref>
###xml 2141 2145 2134 2138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Voll1">[61]</xref>
###xml 2147 2151 2140 2144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Huynh1">[62]</xref>
The Fas/Fas ligand pathway has been implicated as an important cellular pathway mediating apoptosis in diverse cell types [52]. Neutrophils are specifically highly susceptible to rapid apoptosis in vitro after stimulation with activating anti-Fas IgM (mAb CH-11) [53]. Topical treatment of anti-CD95 JO2 treatment does not induce apoptosis in proliferating keratinocytes or macrophages. We utilized this opportunity to set up a Fas-directed approach to increase the apoptotic cell burden at the wound site. The approach reported in this study served as an effective tool to query the significance of apoptotic cell burden on wound biology. Higher apoptotic cell burden at the wound-site resulted in larger open wound indicating a slower rate of closure. Contraction, epithelialization and granulation tissue formation represent the major processes that contribute to the overall wound healing/closure of full thickness dermal wounds. No effect on wound epithelialization yet a slower rate of closure suggests that contraction and/or granulation tissue formation was likely affected under these conditions. Increased apoptotic cells in wounds also resulted in elevated the levels of pro-inflammatory cytokines in wounds supporting the notion that increased apoptotic cell burden at the wound-site results in augmented inflammatory response. This is consistent with previous observation in non-wound studies demonstrating that inappropriate clearance of apoptotic cell corpses lead to chronic inflammation [18]. Both apoptosis as well as the efficient clearance of apoptotic cells are important determinants of the resolution of inflammation in vivo[54], [55], [56]. Phagocytic removal of apoptotic cells by macrophages is a pre-requisite for the restoration of normal tissue function resolving inflammation [56], [57], [58], [59]. Engulfment of apoptotic cells by macrophages results in potent anti-inflammatory and immunosuppressive effects caused by production of anti-inflammatory cytokines such as TGF-beta1, IL-10 & IL-4 and suppressed release of pro-inflammatory mediators including TNF-alpha, IL-6 by activated macrophages [56], [60], [61], [62].
###end p 42
###begin p 43
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Stein1">[63]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Benoit1">[64]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Porcheray1">[65]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Fadok2">[60]</xref>
Macrophages are dynamic and heterogeneous cells. Since the introduction of the concept of alternative activation of macrophages in 1992 [63], these cells have been broadly assigned to two broad groups: (i) classically activated or type I macrophages (M1) which are pro-inflammatory effectors, and (ii) alternatively activated or type II macrophages (M2) that possess anti-inflammatory properties [64]. In response to cues from the microenvironment, pro-inflammatory activated M1 macrophages may switch to M2 [65]. Results of this work support that efferocytosis may be one of such cues that drives the switching of macrophages towards an anti-inflammatory state [60].
###end p 43
###begin p 44
###xml 190 194 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Michlewska1">[66]</xref>
###xml 342 346 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Bystrom1">[67]</xref>
###xml 451 458 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 592 596 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e,</italic>
While efferocytosis orchestrates successful resolution of inflammation, this process is also regulated in an autocrine manner by anti- as well as pro-inflammatory mediators such as TNFalpha [66]. Once inflammation is resolved, the phenotype of resolution-phase macrophages has been shown to be altered primarily via cAMP dependent mechanisms [67]. For the first time, we present functional results from viable macrophages isolated from the wound-site in vivo to directly demonstrate that successful efferocytosis of apoptotic cells results in suppression of a major pro-inflammatory mediator i.e, TNFalpha. Understanding the mechanisms of resolution of inflammation by wound macrophages as well as of the post resolution phenotype of macrophages require further investigation.
###end p 44
###begin p 45
In sum, this study provides first evidence that macrophages from diabetic wounds suffer from impaired in dead cell clearance activity as one of the key factors resulting in increased apoptotic cell burden at the wound site. This burden, in turn, prolongs the inflammatory phase and complicates the healing process and compromises resolution of inflammation. Correction of impaired efferocytosis in diabetic wounds and strategies to intercept the adverse effects of impaired efferocytosis emerge as novel targets for the management of chronic inflammation commonly noted in diabetic wounds.
###end p 45
###begin title 46
Materials and Methods
###end title 46
###begin title 47
Ethics Statement
###end title 47
###begin title 48
Vertebrate animals
###end title 48
###begin p 49
All animal studies have been approved by Ohio State University's Institutional Animal Care and Use Committee (IACUC).
###end p 49
###begin title 50
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects
###end title 50
###begin p 51
###xml 4 9 <span type="species:ncbi:9606">human</span>
All human studies were approved by the Ohio State University's Institutional Review Board (IRB).
###end p 51
###begin title 52
Secondary-Intention Excisional Cutaneous Wound Model
###end title 52
###begin p 53
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Sen1">[68]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy1">[69]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy2">[70]</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Male (8-12 week aged) mice were used for this study. For wounding, mice were anesthetized with isoflurane inhalation. Two 6 mm full-thickness (skin and panniculus carnosus) excisional wounds were placed on the dorsal skin (shaved and cleaned using betadine), equidistant from the midline and adjacent to the four limbs. The wound were left to heal by secondary intention [68], [69], [70].
###end p 53
###begin title 54
Determination of wound area
###end title 54
###begin p 55
###xml 168 172 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Sen1">[68]</xref>
###xml 174 178 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy1">[69]</xref>
###xml 180 184 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy2">[70]</xref>
Imaging of wounds was performed using a digital camera (Canon PowerShot G6). The wound area was determined using WoundMatrixtrade mark software as described previously [68], [69], [70]. All animal studies have been approved by Ohio State University's Institutional Animal Care and Use Committee (IACUC).
###end p 55
###begin title 56
###xml 19 22 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
Polyvinyl Alcohol (PVA) Sponges Implantation
###end title 56
###begin p 57
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Albina1">[71]</xref>
###xml 649 650 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 24 27 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 416 419 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
###xml 687 690 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
Circular (8 mm) sterile PVA sponges were implanted subcutaneously on the back of the mice, a location matched for the site of excisional wounds [71]. In brief, following induction of anesthesia by isofluorane inhalation, dorsal midline was shaved and cleaned with betadine. Two midline 1 cm incisions were made with a scalpel. Small subcutaneous pockets were created by blunt dissection, two pockets per animal. Two PVA sponges were inserted to each pocket. Incisions were closed with skin staples (9 mm) or suture (3-0 Surgilinetrade mark). Animals were then returned to clean cages for the monitoring of recovery. The animals were euthanized by CO2 inhalation for final harvest of the PVA sponges.
###end p 57
###begin title 58
###xml 36 39 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
Isolation of Wound Macrophages from PVA Sponges
###end title 58
###begin p 59
###xml 669 673 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Albina1">[71]</xref>
###xml 675 679 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Efron1">[72]</xref>
###xml 1016 1020 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Efron1">[72]</xref>
###xml 1165 1169 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Efron1">[72]</xref>
###xml 1325 1329 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Schaffer1">[73]</xref>
###xml 1457 1461 1453 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy1">[69]</xref>
###xml 1623 1627 1619 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy1">[69]</xref>
###xml 25 28 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 559 562 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
###xml 1098 1101 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
###xml 1739 1742 <span type="species:ncbi:12215?0.0476878612716763">PVA</span>
Subcutaneously implanted PVA sponges were harvested on a designated day and a single wound cell suspension was generated from sponges by repeated compression. The cell suspension was filtered through a 70 microm nylon cell strainer (Falcon) to remove all the sponge debris. For macrophage isolations, magnetic cell sorting was carried out using mouse anti-CD11b tagged microbeads (Miltenyi Biotec, Auburn, CA). This procedure yields a purified (>95%) population of wound macrophage as determined by F4/80 staining. Subcutaneously implanted polyvinyl alcohol (PVA) sponges are extensively used as model for wound-healing studies especially those addressing inflammation [71], [72]. The model is best suited for acute studies because on a longer term, after about 4 weeks of implantation, it is known to elicit foreign body response resulting in giant cell accumulation and fibrosis. In shorter term studies, the approach represents a reproducible and biologically valid model for the study of acute healing responses [72]. No major differences were noted in the cell characteristics and activity of PVA sponge derived cells and closed incisional wound derived cells [72]. When compared to excisional wounds, some differences that are primarily attributed to low-grade bacterial contamination of open wounds have been reported [73]. In our excisional wound studies, we routinely check wounds for bacterial contaminations using procedures described previously [69]. As reported earlier although low grade contamination is indeed observed in superficial tissues, deep tissue biopsies have not shown any bacterial contamination [69] suggesting that excisional wound deep-tissue macrophages are similar to macrophages derived from the described PVA sponge model.
###end p 59
###begin title 60
Apoptotic Cell Clearance Assay
###end title 60
###begin p 61
###xml 160 167 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009539-g003">Fig. 3A</xref>
###xml 524 531 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 718 722 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Depraetere1">[74]</xref>
###xml 724 728 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Devitt1">[75]</xref>
###xml 961 965 942 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Peters1">[51]</xref>
###xml 1533 1537 1514 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Huynh1">[62]</xref>
For the assay, wound macrophages were seeded in 8-well chambered slides. Apoptotic (5 microM dexamethasone treated for 12 h; yield >90% PS positive thymocytes, Fig. 3A) thymocytes were added to each chamber in a (1:10) macrophage:thymocyte ratio. Prior to co-culture with macrophages, thymocytes were labeled with a fluorescence cell-tracker reagent (CellTrackertrade mark Orange CMTMR, Molecular Probes). Thymocytes have been largely used and are well accepted for efferocytosis studies performed using cultured macrophage ex vivo. Moreover, upon induction of apoptosis, both PMN and thymocytes are known to externalize phosphatidyl serine (PS), one of the key mechanisms of apoptotic cell recognition by macrophages [74], [75]. Phagocytosis assay was performed for 1 h at 37degreesC. In co-culture studies, shorter incubation times (10-15 min) were used for adherence assay while longer (45-60 min) co-culture period were utilized for the phagocytosis assays [51]. Macrophages were then extensively washed to remove non-phagocytosed cells. Cells were fixed with 4% paraformaldehyde and stained using F4/80-FITC. Imaging was performed using a fluorescence microscope (thymocytes, red; macrophage green or phase contrast). Quantitation of phagocytosed thymocytes by each macrophage was performed using Axiovision software (Zeiss) by counting 50-100 macrophages from each well. Data are expressed as "phagocytic index". This index is defined as the total number of apoptotic cells engulfed per macrophage present in the field of view [62]. This approach enables normalization of the data against macrophage number.
###end p 61
###begin title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Subjects and Sample Collection
###end title 62
###begin p 63
###xml 337 344 337 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009539-t001">Table 1</xref>
###xml 699 700 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
Subjects participating in the study were chronic wound patients seen at our Comprehensive Wound Center outpatient clinics that have been either clinically diagnosed type 2 diabetes (n = 3) or no diagnosis of diabetes (non-diabetic, control; n = 3). The demographic characteristics of patients and wound related information are listed in Table 1. Protocols were approved by the Ohio State University's Institutional Review Board. Declaration of Helsinki protocols were followed and patients gave their written, informed consent. Wound (at the wound perimeter) biopsies (3 mm) were obtained from individual subjects, immediately embedded in O.C.T compound (Tissue-Tek(R)) and stored frozen in liquid N2 for histological analysis.
###end p 63
###begin title 64
Histology
###end title 64
###begin p 65
###xml 189 193 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy1">[69]</xref>
###xml 506 510 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy1">[69]</xref>
###xml 281 287 <span type="species:ncbi:9986">rabbit</span>
Formalin-fixed paraffin-embedded or frozen wound specimens were sectioned. Frozen section (10 microm) or deparaffinized paraffin sections (4 microm) were immunostained as described earlier [69] using the anti-active caspase 3 (anti-active caspase 3, Abcam, Inc, Cambridge, MA) and rabbit anti-HNE (Alexis, AXXORA, LLC, san Diego, CA) antibody. The sections were subsequently stained using appropriate HRP or fluorochrome tagged secondary antibody and counterstaining were performed as described previously [69]. For the visualization of wound epithelialization, anti-keratin-14 (1:500; Covance, Berkeley, CA) with appropriate fluorescence tagged secondary antibody was used. Counterstaining was performed with DAPI to visualize nuclei (Molecular probe, OR). Neutrophils and endothelial cells were visualized using anti-neutrophil (1:100, Serotec, Raleigh, NC) and CD31 (1:200, BD Pharmingen, San Diego, CA).
###end p 65
###begin title 66
TUNEL staining
###end title 66
###begin p 67
This assay enables the monitoring of apoptotic cells in tissue sections and was performed using a commercially available kit (DermaTACS, Trevigen Inc).
###end p 67
###begin title 68
Image quantification
###end title 68
###begin p 69
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Underwood1">[76]</xref>
Between 3-5 high powered images were quantified for each data point from each animal. Quantification was performed employing a Image processing tool kit (Adobe Photoshop) software that utilizes a color subtractive process [76].
###end p 69
###begin title 70
Antioxidant Supplementation
###end title 70
###begin p 71
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Kaneto1">[19]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Sablina1">[20]</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
Diabetic (db/db) mice were divided in two equal subgroups. The first group was supplemented (intragastric, daily once) with N-acetylcysteine (NAC) at a dose of 1 mg/g body weight [19], [20]. The control group of mice was supplemented with matched volume of the vehicle (saline).
###end p 71
###begin title 72
Plasma Lipid Peroxidation
###end title 72
###begin p 73
As a marker of lipid peroxidation, plasma malondialdehyde (MDA) levels were detected by the thiobarbituric acid reactive substances (TBARS) method. The assay was performed using OXItek TBARS assay kit (ZeptoMetrix Corporation, Buffalo NY).
###end p 73
###begin title 74
Wound Tissue Cytokine Analysis
###end title 74
###begin p 75
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy2">[70]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Matalka1">[77]</xref>
Wound edge tissue [70] was pulverized under liquid nitrogen followed by extraction of protein in a buffer compatible with ELISA as described [77]. The cytokine levels in tissue extracts were measured using commercially available ELISA kits (R & D Systems).
###end p 75
###begin title 76
Wound Macrophage Cytokine Analysis
###end title 76
###begin p 77
###xml 103 109 <span type="species:ncbi:9913">bovine</span>
Macrophages were seeded in 6-well plates and cultured in RPMI 1640 medium containing 10% heat inactive bovine serum for 24 h under standard culture conditions. After 24 h, the media was collected and the cytokine levels in culture media were measured using commercially available ELISA kits (R & D Systems).
###end p 77
###begin title 78
Western Blot
###end title 78
###begin p 79
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Khanna1">[78]</xref>
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy3">[79]</xref>
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009539-Roy4">[80]</xref>
Western blot was performed as described previously [78], [79], [80]. Primary antibody against active caspase-3 was obtained from Abcam.
###end p 79
###begin title 80
Statistics
###end title 80
###begin p 81
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 148 149 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 201 208 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 281 287 <span type="species:ncbi:9606">humans</span>
In vitro data are reported as mean +/- SD of at least three experiments. Comparisons among multiple groups were made by analysis of variance ANOVA. p<0.05 was considered statistically significant. For in vivo studies, data are reported as mean +/- SD of at least 4-6 animals and 3 humans per group.
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
Antioxidant supplementation to diabetic mice attenuates oxidative stress but does not influence apoptotic cell count in wound tissue. Diabetic db/db mice were supplemented with N-acetyl-cysteine (NAC, 1 mg/g body weight, daily once) for three weeks. The control db/db group was supplemented with matched volume of saline. At the end of three weeks blood glucose, body weight and plasma MDA levels were measured. Two excisional (8 mm punch) wounds were placed on the back of mice. NAC supplementation continued throughout the healing period. A, Plasma lipid peroxidation (MDA levels) as a marker of oxidative stress was measured. Data are mean +/- SD; n = 6. **, p<0.001 compared to non-diabetic (db/+) group. ##, p<0.005 compared to diabetic group supplemented with saline. B, Wound lipid peroxidation was measured using anti-hydroxynonenal (HNE) antibody and immunostaining. Data are mean +/-SD (n = 4), **, p<0.01 compared to diabetic group supplemented with saline. C, Apoptotic cell count in wound tissue sections was measured using active caspase 3 immunohistochemical approach. Quantification (bar graphs) of caspase 3 positive area was performed using Image processing Tool kit. Data are shown as mean +/- SD (n = 4).
###end p 83
###begin p 84
(0.06 MB PDF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
###end article-title 87
###begin article-title 88
Cellular and molecular basis of wound healing in diabetes.[comment].
###end article-title 88
###begin article-title 89
Inflammation in nonhealing diabetic wounds: the space-time continuum does matter.[comment].
###end article-title 89
###begin article-title 90
Chemokines in cutaneous wound healing.
###end article-title 90
###begin article-title 91
Wound healing-aiming for perfect skin regeneration.
###end article-title 91
###begin article-title 92
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.
###end article-title 92
###begin article-title 93
###xml 88 92 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats.
###end article-title 93
###begin article-title 94
Obesity is associated with macrophage accumulation in adipose tissue.[see comment].
###end article-title 94
###begin article-title 95
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages.
###end article-title 95
###begin article-title 96
Cutaneous wound healing.
###end article-title 96
###begin article-title 97
Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.
###end article-title 97
###begin article-title 98
Macrophage phagocytosis of wound neutrophils.
###end article-title 98
###begin article-title 99
The final step in programmed cell death: phagocytes carry apoptotic cells to the grave.
###end article-title 99
###begin article-title 100
Recognition ligands on apoptotic cells: a perspective.
###end article-title 100
###begin article-title 101
Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease.
###end article-title 101
###begin article-title 102
Clearance of apoptotic cells by phagocytes.
###end article-title 102
###begin article-title 103
Clearance: the last and often forgotten stage of apoptosis.
###end article-title 103
###begin article-title 104
Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease.
###end article-title 104
###begin article-title 105
Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.
###end article-title 105
###begin article-title 106
The antioxidant function of the p53 tumor suppressor.[see comment].
###end article-title 106
###begin article-title 107
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.
###end article-title 107
###begin article-title 108
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse models of diabetic nephropathy.
###end article-title 108
###begin article-title 109
Inflammation in wound repair: molecular and cellular mechanisms.
###end article-title 109
###begin article-title 110
Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes.
###end article-title 110
###begin article-title 111
###xml 70 75 <span type="species:ncbi:9606">human</span>
Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages.
###end article-title 111
###begin article-title 112
Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN gamma-treated cultured keratinocytes.
###end article-title 112
###begin article-title 113
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Impairment of monocyte "lectin-like" receptor activity in type 1 (insulin-dependent) diabetic patients.
###end article-title 113
###begin article-title 114
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Altered immune function in alloxan-induced diabetes in mice.
###end article-title 114
###begin article-title 115
Infection and diabetes mellitus.
###end article-title 115
###begin article-title 116
###xml 83 87 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Clearance of apoptotic beta-cells is reduced in neonatal autoimmune diabetes-prone rats.
###end article-title 116
###begin article-title 117
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.
###end article-title 117
###begin article-title 118
Quantifying macrophage defects in type 1 diabetes.
###end article-title 118
###begin article-title 119
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice.
###end article-title 119
###begin article-title 120
Biochemistry and molecular cell biology of diabetic complications.
###end article-title 120
###begin article-title 121
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Clinical significance of neutrophil apoptosis in peripheral blood of patients with type 2 diabetes mellitus.
###end article-title 121
###begin article-title 122
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and {beta}-cell apoptosis.
###end article-title 122
###begin article-title 123
###xml 4 8 <span type="species:ncbi:10090">mice</span>
NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation.
###end article-title 123
###begin article-title 124
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.
###end article-title 124
###begin article-title 125
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Validation of a model for the study of multiple wounds in the diabetic mouse (db/db).
###end article-title 125
###begin article-title 126
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Wound closure and metabolic parameter variability in a db/db mouse model for diabetic ulcers.
###end article-title 126
###begin article-title 127
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Diabetes, a new mutation in the mouse.
###end article-title 127
###begin article-title 128
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.
###end article-title 128
###begin article-title 129
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
###end article-title 129
###begin article-title 130
Regulation of wound healing by growth factors and cytokines.
###end article-title 130
###begin article-title 131
Interleukin-10 and the interleukin-10 receptor.
###end article-title 131
###begin article-title 132
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 93 99 <span type="species:ncbi:10090">murine</span>
Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair.
###end article-title 132
###begin article-title 133
Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue.
###end article-title 133
###begin article-title 134
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair.
###end article-title 134
###begin article-title 135
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice.
###end article-title 135
###begin article-title 136
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice.
###end article-title 136
###begin article-title 137
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation.
###end article-title 137
###begin article-title 138
Programmed cell death in the immune system.
###end article-title 138
###begin article-title 139
###xml 63 68 <span type="species:ncbi:9606">human</span>
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.
###end article-title 139
###begin article-title 140
Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes.
###end article-title 140
###begin article-title 141
Anti-inflammatory lipid mediators and insights into the resolution of inflammation.
###end article-title 141
###begin article-title 142
Apoptosis in resolution of inflammation.
###end article-title 142
###begin article-title 143
The disposal of dying cells in living tissues.
###end article-title 143
###begin article-title 144
Apoptosis: the importance of being eaten.
###end article-title 144
###begin article-title 145
A blast from the past: clearance of apoptotic cells regulates immune responses.
###end article-title 145
###begin article-title 146
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
###end article-title 146
###begin article-title 147
Immunosuppressive effects of apoptotic cells.
###end article-title 147
###begin article-title 148
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.
###end article-title 148
###begin article-title 149
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.
###end article-title 149
###begin article-title 150
Macrophage polarization in bacterial infections.
###end article-title 150
###begin article-title 151
Macrophage activation switching: an asset for the resolution of inflammation.
###end article-title 151
###begin article-title 152
Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha.
###end article-title 152
###begin article-title 153
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP.
###end article-title 153
###begin article-title 154
###xml 65 70 <span type="species:ncbi:9606">human</span>
Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing.
###end article-title 154
###begin article-title 155
Dermal wound healing is subject to redox control.
###end article-title 155
###begin article-title 156
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome.
###end article-title 156
###begin article-title 157
Arginine metabolism in wounds.
###end article-title 157
###begin article-title 158
Subcutaneous sponge models.
###end article-title 158
###begin article-title 159
Wound fluid inhibits wound fibroblast nitric oxide synthesis.
###end article-title 159
###begin article-title 160
"Eat me" signals of apoptotic bodies.
###end article-title 160
###begin article-title 161
Measurement of apoptotic cell clearance in vitro.
###end article-title 161
###begin article-title 162
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model.
###end article-title 162
###begin article-title 163
Measurement of protein cytokines in tissue extracts by enzyme-linked immunosorbent assays: application to lipopolysaccharide-induced differential milieu of cytokines.
###end article-title 163
###begin article-title 164
Regulation of c-SRC activity in glutamate-induced neurodegeneration.
###end article-title 164
###begin article-title 165
Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1).
###end article-title 165
###begin article-title 166
P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts.
###end article-title 166
###begin p 167
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 167
###begin p 168
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by National Institutes of Health (NIH) RO1 award DK076566 to SR, and in part by GM077185 to CKS (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 168

